⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL303253 | 0.98 | — | — | |
| SCHEMBL3186069 | 0.98 | — | — | |
| SCHEMBL19207 | 0.96 | — | — | |
| SCHEMBL3623489 | 0.96 | — | — | |
| SCHEMBL1867164 | 0.96 | — | — | |
| Water SCHEMBL3416842 | 0.94 | — | — | |
| SCHEMBL14763449 | 0.94 | — | — | |
| SCHEMBL31474323 | 0.94 | MMP1 (0.30) | — | |
| Phosphine SCHEMBL19611318 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL31598675 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2302383-A2 | Docetaxel conjugates and immunogens for use in an immunoassay | Saladax Biomedical Inc. (US) | 2011-03-30 | — | — | EP | disclosed |
| EP-2302382-A2 | Docetaxel conjugates and immunogens for use in an immunoassay | Saladax Biomedical Inc. (US) | 2011-03-30 | — | — | EP | disclosed |
| EP-1875237-B1 | DOCETAXEL IMMUNOASSAY | SALADAX BIOMEDICAL INC (US) | 2011-01-05 | — | — | EP | disclosed |
| US-7459281-B2 | Measuring binding of conjugate to monoclonal antibody; determine optimal drug concentrations during chemotherapy and control side effects | SALADAX BIOMEDICAL INC. (US) | 2008-12-02 | — | — | US | disclosed |
| US-20080287658-A1 | Docetaxel Immunoassay | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2008-11-20 | — | — | US | disclosed |
| EP-1875237-A4 | DOCETAXEL IMMUNOASSAY | SALADAX BIOMEDICAL INC (US) | 2008-09-24 | — | — | EP | disclosed |
| EP-1875237-A2 | DOCETAXEL IMMUNOASSAY | Saladax Biomedical Inc. (US) | 2008-01-09 | — | — | EP | disclosed |
| US-20060216769-A1 | Measuring binding of conjugate to monoclonal antibody; determine optimal drug concentrations during chemotherapy and control side effects | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2006-09-28 | — | — | US | disclosed |
| WO-2006102200-A2 | DOCETAXEL IMMUNOASSAY | SALADAX BIOMEDICAL INC. (US) | 2006-09-28 | — | — | WO | disclosed |
| US-20060216767-A1 | Docetaxel immunoassay | SALADAX BIOMEDICAL INC. | 2006-09-28 | — | — | US | disclosed |